World Bulletin / News Desk
A team of global scientists has devised a strategy to find a cure for Aids, an effort inspired by the remarkable story of a single U.S. patient named Timothy Ray Brown who was cured from the disease.
Brown's treatment in Berlin involved the destruction of his immune system and a stem cell transplant from a donor with a rare genetic mutation that resists HIV infection. The procedure is too costly and too difficult to replicate on a large scale.
But in the years since his successful treatment in 2007, Brown's story has become a rallying point for scientists who believe the time is now right to seek a cure for Aids.
Since the Aids epidemic started 31 years ago, scientists have made great strides in treating the disease. Aids-related deaths worldwide fell to 1.7 million last year from some 1.8 million in 2010, according to the latest report from United Nations Aids program (UNAids).
Cocktails of powerful HIV drugs can keep the infection at bay for years, but the virus is wily, weaving itself into the DNA of special immune system cells, where it can lie dormant and out of reach of medications. That makes it necessary for HIV patients to take drugs over a lifetime.
As a result of better access to treatment, more patients with HIV are living near-normal lives, but the numbers of patients needing drugs is rising, increasing the future costs of Aids treatment.
"Treatment is for life, and we know that it is important today and that it can slow the spread of the virus," said Michel Sidibé, executive director of UNAids.
But he said treatment should not be an end in itself.
"If we continue to believe it is the endgame, then we will have a challenge to get to 'zero,'" Sidibé said, referring to the goal of ending the epidemic.
"It's a first step," said Francoise Barre Sinoussi, who won a Nobel prize for her part in identifying human immunodeficiency virus. She is co-chair of the International Working Group Towards an HIV Cure, which released its proposed steps toward a cure on Thursday.
Sinoussi said the next step will be determining the cost-effectiveness of the strategy. That work will begin in conjunction with the International Aids Society's 2012 conference, which runs from July 22-27 in Washington.
GETTING RID OF THE VIRUS
Dr. Steven Deeks of the University of California San Francisco division of HIV/Aids, who is co-chair of the working group, said health professionals see a growing need to "switch from blocking the virus to getting rid of the virus."
Instead of trying to copy the treatment received by Brown, researchers will seek a similar response in a way that is less costly and easier to replicate.
Among the first tasks, according to Deeks, will be to continue basic research in the lab to understand why the virus persists in the body and where it hides out.
Scientists will also need to understand immune system function in HIV-infected patients and determine whether inflammation is playing a role in protecting the virus.
Other teams will need to determine why some patients develop antibodies to the virus, allowing them to control the infection, and whether this can be applied to the search for a cure.
Deeks said doctors need better tests to measure levels of the virus. Researchers will need to develop drugs that flush out the virus from its hiding places in the body, making it more vulnerable to treatment, as well as powerful medications to bolster the immune system's own ability to fight off infection.
Rowena Johnston, of the Foundation for Aids Research, which is helping fund development of a cure, said the global strategy will help consolidate research efforts.
"Now that we know what the questions are, we can focus our efforts in the right direction," she said at a briefing announcing the new push.
Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Disease, a part of the National Institutes of Health, said his agency supports the work but that it is far too early to handicap its success.
"We still have so much discovery to do with regard to a cure that there's no guarantee when or if it will happen. We're sort of where we were over a decade ago with a vaccine," he said.
Back then, scientists were far less certain about vaccine prospects after repeated trial failures, but sentiment changed in 2009 with the first report in Thailand of a modestly successful HIV vaccine trial..
"Now I can say, I'm confident that we'll get a vaccine, I just can't tell you when. With a cure, we're still at the very nascent phase of discovery," Fauci said.
Company will no longer pull data from free Gmail inboxes to personalize ads
Kepler telescope reveals details of more than 200 newly-found planets in Milky Way
"Today, it is our pleasure to officially announce the newest member of our 737 family, the 737 MAX 10," Kevin McAllister, head of the company's commercial aviation division, told journalists as the Paris Air Show got under way.
The Twilight Express Mizukaze departed Osaka on its maiden trip with around 30 well-heeled passengers on a journey to the far reaches of Japan's main island.
Google has launched a website to help you find the Qibla – the direction of prayer.
Bilkent University students designed Arbo which can babysit and notify of gas leaks in the house
The refurbished Dragon cargo capsule soared into space aboard a Falcon 9 rocket at 5:07 pm (2107 GMT) from Cape Canaveral, Florida.
The deal enables GE's "Geneva" to communicate with the Google Assistant, so users can say: "Ok Google, ask Geneva Home to set the oven timer for 10 minutes."
The plane took off from the Siberian city of Irkutsk where the Irkut company is based, said Deputy Prime Minister Dmitry Rogozin, writing on Twitter.
A NASA statement described the planet as "a complex, gigantic, turbulent world" that is far different than scientists previously thought.
Scientists have completed initial study in Antarctica to establish Turkey's first base on the continent
According to documents released in March by Wikileaks, US intelligence can hack smartphones, computers and smart, web-connected TVs, to pilot them and eavesdrop.
"IOT home appliances, things that can be used in our everyday lives, our cars, lights, refrigerators, everything like this that is connected can be used and weaponised to spy on us or harm us."
The malware uses a hacking tool known as EternalBlue, which was published last month by an anonymous hacking group called Shadow Brokers, saying it had been obtained from the US National Security Agency.